Imojev product information
WitrynaProduct and Consumer Medicine Information. PI & CMI Trade Names and Active Ingredients containing denosumab. 2 Documents available. Need more information on a product? WitrynaNPS MedicineWise
Imojev product information
Did you know?
WitrynaA white to creamy white homogeneous cake which might be retracted. The way to take this medicine is: Subcutaneous. This medicine is injected, usually with a short needle … Witryna27 wrz 2024 · Before using Imojev Powder, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), …
WitrynaThe product should be used once reconstituted and must be discarded if it is not used within one hour of reconstitution. ... Imojev, of the two first doses and the third dose of the inactivated JE comparator vaccine and of the placebo doses. . imoj-ccdsv10-piv5-18mar20 Page 7 of 21 WitrynaProduct information. Documents providing officially approved information for healthcare professionals and patients on a medicine. The product information includes the summary of product characteristics, package leaflet and labelling. More information can be found under ' Product-information requirements '.
WitrynaEach 0.5 mL monodose pre-filled syringe contains: 6 antigen units of purified inactivated Japanese encephalitis virus. 0.25 mg aluminium as aluminium hydroxide. No preservatives or antibiotics are added. For Product Information and Consumer Medicine Information about JEspect visit the Therapeutic Goods Administration website. WitrynaBreastfeeding women should not receive Imojev® because it is not known whether the virus is excreted in breast milk. People who have received immunoglobulin or blood …
WitrynaAustralian Register of Therapeutic Goods (ARTG) information for IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial. Skip …
WitrynaAusPAR Imojev Sanofi-Aventis Australia Pty Ltd PM-2012-02264-3-2Final 3 February 2014. Page 30 of 30. ... The Product Information approved at the time this AusPAR was published is at Attachment 1. For the most recent Product Information please refer to the TGA website at < fz szuWitrynaPopulation pédiatrique (9 mois à 17 ans révolus). Une dose de rappel du vaccin Imojev doit être administrée après la primovaccination afin de conférer à l'enfant une … fz t 60021Witrynareceive Imojev® because it is not known whether the virus is excreted in breast milk. – People who have received immunoglobulin or blood product administration. Do not … fz t 81007Witryna7 mar 2024 · Pengertian . Imojev adalah vaksin dalam bentuk cairan injeksi yang memiliki komposisi virus yang dilemahkan (ensefalitis). Vaksin ini digunakan sebagai … fz t 81004WitrynaHow IMOJEV is given Possible side effects Storing IMOJEV Further information What IMOJEV is and what it is used for IMOJEV is a vaccine that helps to protect you or … atos oy taloustiedotWitrynaOne of these vaccines, IMOJEV (®) (JE-CV and previously known as ChimeriVax™-JE), is a novel recombinant chimeric virus vaccine, developed using the Yellow fever virus … atos notariais onlineatos onepoint